Jefferies Financial, MillerKnoll dip premarket; Kodiak Sciences surges By Investing.com

U.S. stock futures dropped roughly 0.8% (Dow futures -351 pts, S&P and Nasdaq futures ~-0.8% to -0.9%) as Middle East fighting and U.S.-Iran negotiation reports drove risk-off flows; oil jumped back above $100/barrel. Energy names Exxon and Chevron rose while airlines, cruise operators and miners retreated; Jefferies shares fell >1.8% after loan losses offset investment banking gains. Tech names including Micron and Sandisk slipped on a Google compression proposal, while biotech and travel winners (Kodiak, Preceigen, Navan) moved higher and MillerKnoll slumped after a weak fiscal Q4 outlook.

Analysis

The current risk-premia repricing allocates cashflow toward energy producers and away from demand-sensitive service sectors; mechanically this raises free-cash-flow conversion for upstream producers while compressing airline and cruise operating margins via higher unit fuel costs and longer lead-time pass-through to consumers. Second-order supply-chain transmission is more important than headline moves: higher shipping and bunker costs propagate 6–12 months into retail and industrial margins, benefiting vertically integrated miners and refiners while pressuring branded consumer goods with thin inventories.

Credit implications are non-trivial — the same shock that dents travel revenue increases default probability for levered, niche lenders and specialty finance arms within a two–four quarter window, forcing higher loan-loss provisioning and flatter ROE. On technology, a structural improvement in compression algorithms reduces marginal DRAM content growth; that favors cloud owners who internalize gains in TCO while pressuring commodity memory vendors’ ASPs over 12–24 months.

Catalysts that would reverse the flow are diplomatic breakthroughs or coordinated SPR releases, which can normalize risk premia in weeks, versus sustained geopolitical escalation that embeds structural higher-price baselines for months. Consensus underprices optionality on idiosyncratic biotech catalysts and overprices linear demand destruction in travel — tactical opportunities exist in paired trades that harvest energy skew while shorting credits and travel beta.

Key Decisions for Investors

• Long integrated energy via XOM/CVX 6–12 month call spreads (buy 6–12m 25–35 delta calls, sell 6–12m 10–15 delta calls) sized to 3–5% NAV; target 30–50% return if energy risk premia persist, stop at 12% premium decay — rationale: captures producer FCF recovery while limiting theta exposure.
• Pair trade: short UAL/DAL vs long XOM (dollar-neutral) over 1–3 months — short 3m 30–35 delta puts or buy 3m OTM puts on UAL/DAL to capture downside from margin compression, size 2–3% NAV short leg; target 15–25% downside in airlines with stop at 8–10% premium increase. This hedges macro beta while keeping upside from energy exposure.
• Short JEF via 6–9 month puts or small outright short (size 1–2% NAV) — thesis: idiosyncratic credit provisioning will pressure EPS over next two quarters, target 20% downside, stop at 10% adverse move. Consider buying protection to keep tail risk finite.
• Tactical long-binary on KOD (biotech) via 3–6 month OTM calls (low notional, 0.5–1% NAV) — asymmetric payoff: objective is to capture trial-driven re-rating with >2x upside while limiting capital at risk; trim quickly on 30–50% paper gain given binary nature.